Pharma Foods International (2929) · InitiativeAdvanced
Venture Capital Business Conducted by PF Capital
First written in FY2022. 1 of 2 entries say "Advanced", first in FY2023-Q2. Latest entry: FY2023-Q2.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
CVC investment in startups and technology acquisitionA theme 26 companies write about · 0 as a headwind · 26 as a tailwind
The whole theme swung hardest in 2018: 1 of 6 companies on the "Worse" side.
11 other companies' latest entry also says "Advanced".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 26 companies compared. The sentences above are computed from all 26.Full recordFilings, disclosures and news, newest first
- FY2023-Q2AdvancedAnnual report
「At a meeting of the Board of Directors held on 23 January 2023, the company resolved to establish PF Visionary Fund Investment Limited Partnership to rapidly accelerate innovation going forward in its antibody drug discovery and healthcare businesses based on its “ALAgene technology,” and entered into the agreement on the same date.」
With respect to PF Capital's venture capital business, PF Visionary Fund was established to accelerate innovation in antibody drug discovery through ALAgene technology and in the healthcare business. - FY2022First statedAnnual report
「As another business, subsidiary PF Capital conducts a venture capital business.」
Through the conversion of そーせいCVC into a subsidiary and the change of its corporate name to PF Capital, the company has positioned the venture capital business as a new business for the Group.